Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-02-10
DOI
https://doi.org/10.3390/cancers18040572
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425

Chris W. Govaerts, Mathilde Jalving, Ingeborg Bosma, Anouk van der Hoorn et al.
Cancers
Brain Metastases and Treatment
article

Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425

Chris W. Govaerts, Mathilde Jalving, Ingeborg Bosma, Anouk van der Hoorn, Frederike Bensch, Kramer Mc, Frank A. E. Kruyt, J. Marc C. van Dijk
article en

Abstract

No abstract available for this paper.
CancersVol. 18(4)
University Medical Center Groningen (NL), University of Groningen (NL)
Openalex Percentile: Top 63%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.